The effect of estroprogestagen therapy on lipid status in menopause depending on the drug administration route

The effect of estroprogestagen therapy on lipid status in menopause depending on the drug administration route

Background/Aim. In menopausal women lipid and lipoprotein values are important predictors of development of cardiovascular diseases (CVD). The use of estrogens reduces levels of low density lipoprotein cholesterol (LDLC) and lipoprotein A [Lp(a)], and increases levels of triglycerides (TG) and high...

Full description

Bibliographic Details
Main Authors: Čitlučanin Goran, Ivović Miomira, Tančić-Gajić Milina, Canović Fadil, Stojanović Miloš, Marina Ljiljana, Arizanović Zorana, Đogo Aleksandar, Gerginić Vladimir, Vujović Svetlana
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2020-01-01
Series:Vojnosanitetski Pregled
Subjects:
hormone replacement therapy
cardiovascular diseases
lipids
menopause
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501800080C.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501800080C.pdf

Similar Items